Biotechnology
What if Europe became a leader in biotech innovation?
Unleashing Europe’s biotech prowess requires radical reinvention
Covid-19 vaccine-maker BioNTech to acquire former rival CureVac
French researchers to Macron: Take care of us before wooing Americans
Dutch government plans to screen scientists for national security risks
Innovation can help unlock the future of European agriculture
Europe looks to poach US researchers as Trump cuts funding
Twelve EU capitals want programs to bring over American scholars.
Oxford University’s China dilemma
Politicians are among those vying to run the elite institution — and they’re squaring off over Beijing’s influence on Britain.
The future EU commissioners’ promises: Everything you need to know
We pored over more than 400 pages of written answers so you don’t have to.
This burger could kill the EU
Farmers furious about lab-grown meat are taking their fight to the heart of the European project.
Open Access: A Moral Imperative for Progress
There is a moral imperative to make scientific research freely available. Publicly funded research should be publicly accessible. Accelerating research availability can save lives, support researchers’ careers, and create a brighter future.
Open Strategic Autonomy for plasma therapies in the EU
We can meet the needs of EU patients who rely on plasma therapies — and the EU’s goals for strategic autonomy — by ensuring a vibrant plasma-based biotech sector.
Europe’s Silicon Valley? Cambridge says no thanks
The UK has grand plans — but the city has other ideas.
Billionaire-backed think tank played key role in Biden’s AI order
Researchers from the RAND Corporation — which took more than $15 million this year from a group financed by a Facebook co-founder — were a driving force behind the White House’s sweeping new AI reporting requirements.
Taking medicines from bench to bedside
The ongoing review of the EU Pharmaceutical Legislation is looking at recalibrating IP incentives. Intellectual Property fuels medical innovations from the research bench to the patient’s bedside.
UK Chancellor Jeremy Hunt defends China’s invitation to AI summit
Hunt begins a multi-day visit to major US tech companies on Wednesday as the country aims to expand its own artificial intelligence and life sciences industries.
Biden sets new rules restricting US investments in China
The executive order, aimed at slowing Beijing’s military development, represents the first time Washington has exerted broad oversight on American business overseas.
6 things that threaten Europe, according to … the EU
Commission unveiled its annual strategic foresight report, setting out its focus for the coming years.
OpenAI, DeepMind will open up models to UK government
LONDON — Google DeepMind, OpenAI and Anthropic have agreed to open up their AI models to the U.K. government for research and safety purposes, Prime Minister Rishi …
Happy pills: How Sweden and Denmark became rare bright spots for Europe’s pharma industry
While in most of Europe the sector is in a funk, the two Northern European countries are bucking the trend.
Copenhagen: The safe, healthy congress capital of life and science
Peaceful, secure, healthy and equitable, Copenhagen has become a global capital for life science – supported by a new, fruitful partnership between the public and private sectors and academia: Copenhagen Life Science.
The real reason Europe’s medicines industry is dying
The bloc risks becoming a drug importer rather than an innovator.
EU transparency commissioner: No conflict of interest for Ursula von der Leyen’s husband
Green lawmakers had raised concerns about Heiko von der Leyen’s role in a biotech company that received EU funds.
The EU butts heads with Big Pharma to make medicines cheaper
The bloc’s pharma reform aims to get new drugs to patients faster, for less money. But it clashes with the industry’s priorities.
From dependence to autonomy: curing Europe’s health care ecosystem
The COVID-19 pandemic posed a very worrying question: what happens when you are totally reliant on other countries for access to life-saving medicines?
Will EU prosecutor’s COVID vaccine probe ensnare von der Leyen?
The prosecutor has given no hints so far, so POLITICO’s here with a rundown of what the investigation may — and may not — be looking at.
Inflation hits medicines manufacturers, threatens UK supplies
Generic drugmakers with thin margins and locked-in contracts are seeing some products become loss-making.
Too many cooks? Flurry of world hunger plans risks misfiring
Politicians urge greater coordination on food security as millions face acute hunger.